ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:27 am Sale | 2023-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | ADAGE CAPITAL PARTNERS GP L.L.C. | 465,381 1.550% | -1,083,210 (-69.95%) | Filing |
| 2023-02-02 4:45 pm Purchase | 2023-01-23 | 13G | BioXcel Therapeutics, Inc. BTAI | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,548,591 5.530% | 1,548,591 (New Position) | Filing |